Articles | Volume 10, issue 4
https://doi.org/10.5194/jbji-10-327-2025
https://doi.org/10.5194/jbji-10-327-2025
Original full-length article
 | 
29 Aug 2025
Original full-length article |  | 29 Aug 2025

CarboCell G/C offers high and prolonged concentrations of gentamicin and clindamycin in bone tissue following intraosseous injection

Mads Kristian Duborg Mikkelsen, Andrea René Jørgensen, Niranjan G. Kotla, Maiken Stilling, Maria Bech Damsgaard, Christoph Crocoll, Michal Poborsky, Hans Christian Rasmussen, Jonas Rosager Henriksen, Anders Elias Hansen, and Mats Bue

Viewed

Total article views: 29 (including HTML, PDF, and XML)
HTML PDF XML Total Supplement BibTeX EndNote
22 6 1 29 2 0 0
  • HTML: 22
  • PDF: 6
  • XML: 1
  • Total: 29
  • Supplement: 2
  • BibTeX: 0
  • EndNote: 0
Views and downloads (calculated since 29 Aug 2025)
Cumulative views and downloads (calculated since 29 Aug 2025)

Viewed (geographical distribution)

Total article views: 29 (including HTML, PDF, and XML) Thereof 29 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 30 Aug 2025
Download
Short summary
In recent decades, there has been a growing emphasis on the use of local antibiotics in orthopaedic surgery, but development of new technologies has been limited. In this study we observe that a 1.5 mL injection of the novel technology CarboCell G/C into the bone provides very high levels of the antibiotics gentamicin and clindamycin in bones, with almost no spill to the bloodstream. These findings bolster the prospect of new and improved technologies for combatting orthopaedic infections.
Share